First-of-Its-Kind Vaccine Ushers in New Hope for Cancer Patients The New York Times News New York Times highlights advancements in cancer vaccines. The feature outlines pioneering research by Penn Medicine's Dr. Susan Domchek and Dr. Robert Vonderheide, focusing on training the immune system to intercept cancer early. Latest News Preclinical Study Addresses a Question: Should RAS Inhibitors Be Given Preemptively for Pancreatic Cancer? ASCO Post News | May 2026 Breast Cancer Driven by Germline TP53 Mutations Springer Nature Research Communities News | May 2026 Breast Cancer Driven by Germline TP53 Mutations Springer Nature Research Communities News | May 2026 Distinct Genomic and Immunologic Tumor Evolution in Germline TP53-Driven Breast Cancers Nature Communications News | May 2026 Should You Get Tested for Lynch Syndrome? Doctissimo News | April 2026 Researchers Explore New Strategy to Stop Pancreatic Cancer Before It Develops Precision Medicine News | April 2026 What You Need To Know About Blood Tests For Cancer Forbes News | March 2026 What’s Lynch Syndrome? The Hidden Genetic Risk Behind Multiple Cancers HuffPost News | March 2026 Penn Medicine Launches King Center for Lynch Syndrome Philadelphia Inquirer News | March 2026 Abramson Cancer Center Director Elected to Lead American Association for Cancer Research Penn Medicine News News | March 2026 Robert H. Vonderheide, MD, DPhil, FAACR, Elected as American Association for Cancer Research President-Elect for 2026-2027 AACR News | March 2026 KRAS Inhibitors Intercept Pancreatic Cancer Before It Develops in Mice Inside Precision Medicine News | March 2026 New Strategy Intercepts Pancreatic Cancer by Eliminating Microscopic Lesions Before They Become Cancer Penn Medicine News | March 2026 New Strategy Halts Pancreatic Cancer by Targeting Microscopic Lesions Before Tumor Development Bioengineer.org News | March 2026 Penn Medicine Donors Amidst National Philanthropy 50 The Associated Press News | March 2026 New AACR Partnership on Early Detection of High-risk Cancers AACR Cancer Research Catalyst News | February 2026 Basser Center for BRCA Announces Two Award Winners ASCO Post News | December 2025 Mid Penn Bank Donates $100,000 to Penn Medicine’s Basser Center for BRCA BucksCo Today News | November 2025 Pagination First page« First Previous page‹‹ Page1 Current page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 … Next page›› Last pageLast »
First-of-Its-Kind Vaccine Ushers in New Hope for Cancer Patients The New York Times News New York Times highlights advancements in cancer vaccines. The feature outlines pioneering research by Penn Medicine's Dr. Susan Domchek and Dr. Robert Vonderheide, focusing on training the immune system to intercept cancer early.
Preclinical Study Addresses a Question: Should RAS Inhibitors Be Given Preemptively for Pancreatic Cancer? ASCO Post News | May 2026
Distinct Genomic and Immunologic Tumor Evolution in Germline TP53-Driven Breast Cancers Nature Communications News | May 2026
Researchers Explore New Strategy to Stop Pancreatic Cancer Before It Develops Precision Medicine News | April 2026
Abramson Cancer Center Director Elected to Lead American Association for Cancer Research Penn Medicine News News | March 2026
Robert H. Vonderheide, MD, DPhil, FAACR, Elected as American Association for Cancer Research President-Elect for 2026-2027 AACR News | March 2026
KRAS Inhibitors Intercept Pancreatic Cancer Before It Develops in Mice Inside Precision Medicine News | March 2026
New Strategy Intercepts Pancreatic Cancer by Eliminating Microscopic Lesions Before They Become Cancer Penn Medicine News | March 2026
New Strategy Halts Pancreatic Cancer by Targeting Microscopic Lesions Before Tumor Development Bioengineer.org News | March 2026
New AACR Partnership on Early Detection of High-risk Cancers AACR Cancer Research Catalyst News | February 2026
Mid Penn Bank Donates $100,000 to Penn Medicine’s Basser Center for BRCA BucksCo Today News | November 2025
